Saroja Pharma Industries India Ltd vs Vikas Wsp Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 23, 2026

Key Highlights

The Latest Trading Price of Saroja Pharma Industries India Ltd is ₹ 28.15 as of 23 Mar 09:48 . The P/E Ratio of Saroja Pharma Industries India Ltd changed from 16.1 on March 2024 to 14.7 on March 2025 . This represents a CAGR of -4.45% over 2 yearsThe P/E Ratio of Vikas Wsp Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore on March 2024 to ₹ 15.18 crore on March 2025 . This represents a CAGR of 3.72% over 2 yearsThe Market Cap of Vikas Wsp Ltd changed from ₹ 121.44 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vikas Wsp Ltd for the Dec '25 is ₹ 0.06 crore as compare to the Sep '25 revenue of ₹ 0.05 crore. This represent the growth of 20% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vikas Wsp Ltd for the Dec '25 is ₹ -0.18 crore as compare to the Sep '25 ebitda of ₹ -0.22 crore. This represent the decline of -18.18% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Vikas Wsp Ltd changed from ₹ -8.77 crore to ₹ -8.72 crore over 7 quarters. This represents a CAGR of -0.33% The Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vikas Wsp Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

About Vikas Wsp Ltd

Vikas Wsp Limited (Formerly known as Vikas Gum Mills Pvt Ltd.) was established in 1988.
The Company was converted into a Public Limited in September, 1992.
Guar water soluble polymers (GWSP), an effective water retention agent manufactured by its 100% EoU since Sep.'90, is a natural polymer which is extensively used in the food and pharmaceutical industries. The Company is one of the India's foremost guar gum powder (GGP) manufacturer, supplying to all sectors of the food industry with an extensive range of quality products.
Besides food, the Company also offers guar gum for technical applications such as pet food, oil drilling and fracturing, textile printing, mining paper, etc.
Per annum production capacity of all grades guar gum powder is 46200 MT. In Sep, 1995, it set up a unit with production capacity of 3600 TPA of Guar Derivatives (GD).

FAQs for the comparison of Saroja Pharma Industries India Ltd and Vikas Wsp Ltd

Which company has a larger market capitalization, Saroja Pharma Industries India Ltd or Vikas Wsp Ltd?

Market cap of Saroja Pharma Industries India Ltd is 11 Cr while Market cap of Vikas Wsp Ltd is 19 Cr

What are the key factors driving the stock performance of Saroja Pharma Industries India Ltd and Vikas Wsp Ltd?

The stock performance of Saroja Pharma Industries India Ltd and Vikas Wsp Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Saroja Pharma Industries India Ltd and Vikas Wsp Ltd?

As of March 23, 2026, the Saroja Pharma Industries India Ltd stock price is INR ₹28.15. On the other hand, Vikas Wsp Ltd stock price is INR ₹0.93.

How do dividend payouts of Saroja Pharma Industries India Ltd and Vikas Wsp Ltd compare?

To compare the dividend payouts of Saroja Pharma Industries India Ltd and Vikas Wsp Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.